Fukue, Ryosuke
Okazaki, Yuka
Gono, Takahisa
Kuwana, Masataka
Article History
Received: 26 February 2022
Accepted: 3 August 2022
First Online: 13 August 2022
Declarations
:
: This study was approved by the Ethics Committee of Nippon Medical School Hospital (approval number 27-10-507 and 30-09-992). Written informed consent was obtained from all subjects prior to collecting samples in accordance with the tenets of the Declaration of Helsinki.
: Not applicable.
: MK has received research grants and personal fees from Boehringer Ingelheim, Ono Pharmaceuticals, and MBL, as well as personal fees from AbbVie, Asahi Kasei Pharma, Astellas, Chugai, Corbus, Eisai, GlaxoSmithKline, Janssen, Mochida, Nippon Shinyaku, and Tanabe-Mitsubishi.